MedTrace Logo

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients

NCT00626756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2008-02-29

No results posted yet for this study

Summary

Hypothesis: Fluid management guided by LiDCO doesn´t increase cumulative fluid balance and shorten organ dysfunction compared to fluid management based on CVP and clinical judgment.

Conditions

  • Critical Illness

Interventions

DEVICE

LiDCO technology

non invasive monitoring of cardiac output

Sponsors & Collaborators

  • ASQA a.s.

    lead INDUSTRY

Principal Investigators

  • Vladimir Cerny, MD, PhD, FCCM · University Hospital Hradec Kralove

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00626756 on ClinicalTrials.gov